Skip to content

USEFULNESS OF HOMOEOPATHY IN ATOPIC DERMATITIS

AN OPEN OBSERVATIONAL TRIAL TO EVALUATE THE EFFECTIVENESS OF INDIVIDUALISED HOMOEOPATHIC MEDICINES IN THE TREATMENTOF ATOPIC DERMATITIS USING SYNTHESIS REPERTORY

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/01/017074
Enrollment
54
Registered
2019-01-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L20- Atopic dermatitis

Interventions

Intervention1: Individualised homoeopathic medicine in centensimal and fifty millesimal potency.: Intervention is planned as administering indicated homoeopathic medicines (selected with the help of S
dosage and repetition depending upon the individual requirement of the cases. In 50 millesimal scale, a single medicated cane sugar globule of poppy seed size (no. 10) shall be dissolved in 90 ml dist
16 doses to be marked on the vial
each dose of 5 ml to be taken after 10 uniformly forceful downward strokes to the vial in 45 ml normal water in a clean cup, to stir well, to take 5 ml of this liquid orally, and to discard rest of th

Sponsors

NATIONAL INSTITUTE OF HOMOEOPATHY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Cases suffering from atopic dermatitis diagnosed by UK Diagnostic crieteria(as per ICD L20.9 2. both sexes 3. giving written consent to participate in trial. 4 patients already undergoing regular oral/topical conventional therapy for AD can be recruited only if medications are stopped completely.

Exclusion criteria

Exclusion criteria: 1.Patients who are too sick for consultation 2 unwilling to take part and not giving written consent to join the study. 3.diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life -threatning illness affecting quality of life. 4.pregnancy and lactation 5.substance abuse and or dependence 6 undergoing homoeopathic treatment for any chronic disease with in last 6months.

Design outcomes

Primary

MeasureTime frame
Primary outcome POSCORAD[18] index is a scale to assess the severity of AD , includes two parameter one is intensity and other is areas involvedTimepoint: baseline and three months

Secondary

MeasureTime frame
(1) Dermatological Life Quality index The scoring of each question Very much scored 3 A lot scored 2 A little scored 1 Not at all scored 0 Not relevant scored 0 Question 7 , â??prevented work or studying scored 3 (2) ATOPIC DERMATITIS BURDEN SCALE FOR ADULTS[22] assesed as never, rarely, sometimes, often, very often and constantly. score is interpreted as follows: 9.75 or below mild 9.76 to 20.61 moderate 20.62 to 33.52 or above severeTimepoint: baseline and three months

Countries

India

Contacts

Public ContactAVIJIT SHEE BURMAN

National Institute of Homoeopathy

asheeburman@gmail.com9433392108

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026